| Ms Telsa Dawn Henlon, ARNP | |
|
1821 Sw 124th Way, Miramar, FL 33027-2533 | |
| (954) 437-1802 | |
| Not Available |
| Full Name | Ms Telsa Dawn Henlon |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 1821 Sw 124th Way, Miramar, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053422766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1466692 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Telsa Dawn Henlon, ARNP 1821 Sw 124th Way, Miramar, FL 33027-2533 Ph: (954) 437-1802 | Ms Telsa Dawn Henlon, ARNP 1821 Sw 124th Way, Miramar, FL 33027-2533 Ph: (954) 437-1802 |
News Archive
Intuition is all one needs to understand that stress in early childhood can create lifelong psychological troubles, but scientists have only begun to explain how those emerge in the brain.
A new biologic agent-the most potent of its kind so far-is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited today announced that brentuximab vedotin (SGN-35) will be featured in two oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 4-7, 2010 in Orlando, FL.
New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.
Research scientists from Massachusetts General Hospital, Boston, have developed a novel bioengineered treatment that has shown promise in targeting pancreatic cancer without causing damage to healthy noncancer cells, a typical problem of chemotherapy.
› Verified 2 days ago
Jennifer Richards, ARNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 3720 Executive Way Ste 106, Miramar, FL 33025 Phone: 877-868-4827 | |
Ivon Gonzalez, A.N.R.P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3220 S Douglas Rd Ste A, Miramar, FL 33025 Phone: 954-436-8444 Fax: 954-436-1159 | |
Claudline Pierre Louis, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6300 Sw 35th Ct, Miramar, FL 33023 Phone: 786-200-0227 | |
Marie S Laguerre, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13793 Sw 26th St, Miramar, FL 33027 Phone: 305-987-4198 Fax: 954-433-4622 | |
Mrs. Marie Monique Charles, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3400 Knolls Rd, Miramar, FL 33025 Phone: 305-491-3396 | |
Ashley E Huergo, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14601 Sw 37th St, Miramar, FL 33027 Phone: 786-942-8781 | |
Katiana Legagneur, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2341 Pine Tree Dr, Miramar, FL 33023 Phone: 239-324-6854 |